These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36597770)

  • 1. Volatile metabolites differentiate air-liquid interface cultures after infection with
    Ahmed W; Bardin E; Davis MD; Sermet-Gaudelus I; Grassin Delyle S; Fowler SJ
    Analyst; 2023 Jan; 148(3):618-627. PubMed ID: 36597770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Staphylococcus aureus in cystic fibrosis patients using breath VOC profiles.
    Neerincx AH; Geurts BP; van Loon J; Tiemes V; Jansen JJ; Harren FJ; Kluijtmans LA; Merkus PJ; Cristescu SM; Buydens LM; Wevers RA
    J Breath Res; 2016 Nov; 10(4):046014. PubMed ID: 27902490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.
    Filipiak W; Sponring A; Baur MM; Filipiak A; Ager C; Wiesenhofer H; Nagl M; Troppmair J; Amann A
    BMC Microbiol; 2012 Jun; 12():113. PubMed ID: 22716902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Analysis of Volatile Metabolites Synthesized by
    Filipiak W; Wenzel M; Ager C; Mayhew CA; Bogiel T; Włodarski R; Nagl M
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of microorganisms based on headspace analysis of volatile organic compounds by gas chromatography-mass spectrometry.
    Boots AW; Smolinska A; van Berkel JJ; Fijten RR; Stobberingh EE; Boumans ML; Moonen EJ; Wouters EF; Dallinga JW; Van Schooten FJ
    J Breath Res; 2014 Jun; 8(2):027106. PubMed ID: 24737039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of volatile organic biomarkers derived from Plasmodium falciparum in vitro.
    Wong RP; Flematti GR; Davis TM
    Malar J; 2012 Sep; 11():314. PubMed ID: 22958460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
    Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
    J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Headspace volatile organic compounds from bacteria implicated in ventilator-associated pneumonia analysed by TD-GC/MS.
    Lawal O; Muhamadali H; Ahmed WM; White IR; Nijsen TME; Goodacre R; Fowler SJ
    J Breath Res; 2018 Jan; 12(2):026002. PubMed ID: 28947683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-induced Volatile Organic Compounds Are Detectable in Exhaled Breath during Pulmonary Infection.
    Kamal F; Kumar S; Edwards MR; Veselkov K; Belluomo I; Kebadze T; Romano A; Trujillo-Torralbo MB; Shahridan Faiez T; Walton R; Ritchie AI; Wiseman DJ; Laponogov I; Donaldson G; Wedzicha JA; Johnston SL; Singanayagam A; Hanna GB
    Am J Respir Crit Care Med; 2021 Nov; 204(9):1075-1085. PubMed ID: 34319857
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in lung epithelial cell volatile metabolite profile induced by pro-fibrotic stimulation with TGF-
    Hayton C; Ahmed W; Cunningham P; Piper-Hanley K; Pearmain L; Chaudhuri N; Leonard C; Blaikley JF; Fowler SJ
    J Breath Res; 2023 Sep; 17(4):. PubMed ID: 37619557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological variability in volatile organic compounds (VOCs) in exhaled breath and released from faeces due to nutrition and somatic growth in a standardized caprine animal model.
    Fischer S; Trefz P; Bergmann A; Steffens M; Ziller M; Miekisch W; Schubert JS; Köhler H; Reinhold P
    J Breath Res; 2015 May; 9(2):027108. PubMed ID: 25971714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of media on the differentiation of Staphylococcus spp. by volatile compounds.
    Jenkins CL; Bean HD
    J Breath Res; 2019 Nov; 14(1):016007. PubMed ID: 31461416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid method for breath analysis in cystic fibrosis patients.
    Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of pulmonary bacterial pathogens in cystic fibrosis by volatile metabolites emitted by their in vitro cultures: Pseudomonas aeruginosa, Staphylococcus aureus, Stenotrophomonas maltophilia and the Burkholderia cepacia complex.
    Dryahina K; Sovová K; Nemec A; Španěl P
    J Breath Res; 2016 Aug; 10(3):037102. PubMed ID: 27506232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis.
    Shestivska V; Dryahina K; Nunvář J; Sovová K; Elhottová D; Nemec A; Smith D; Španěl P
    J Breath Res; 2015 Apr; 9(2):027104. PubMed ID: 25830686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air.
    Meyer N; Dallinga JW; Nuss SJ; Moonen EJ; van Berkel JJ; Akdis C; van Schooten FJ; Menz G
    Respir Res; 2014 Nov; 15(1):136. PubMed ID: 25431084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial Volatiles as Diagnostic Biomarkers of Bacterial Lung Infection in Mechanically Ventilated Patients.
    Ahmed WM; Fenn D; White IR; Dixon B; Nijsen TME; Knobel HH; Brinkman P; Van Oort PMP; Schultz MJ; Dark P; Goodacre R; Felton T; Bos LDJ; Fowler SJ;
    Clin Infect Dis; 2023 Mar; 76(6):1059-1066. PubMed ID: 36310531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.